See also this year's filing and all EDGAR filings for this company.
PDF Report 0001267813_2022_Marinus_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 2.673828406633021, 'aggregate_val': 25478000, 'exp_sum': 6935000, 'exp_to_value': {'remainder_Revenues': 6935000}} |
Graph
Absolute values for 0001267813, Marinus Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 131,678,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,499,000 |
| 3 | remainder_Assets | 2,663,000 |
| 4 | LiabilitiesCurrent | 40,566,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 42,788,000 |
| 7 | CostOfGoodsAndServicesSold | 1,478,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 37,278,000 |
| 9 | ResearchAndDevelopmentExpense | 73,520,000 |
| 10 | remainder_Expenses | 2,567,870 |
| 11 | remainder_Revenues | 15,345,000 |
| 12 | remainder_NetIncome | 2,463,624 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 136,840,000 |
| 1 | Liabilities | 83,354,000 |
| 2 | Expenses | 114,843,870 |
| 3 | Revenues | 15,345,000 |
| 4 | StockholdersEquity | 53,486,000 |
| 5 | NetIncome | -97,035,246 |
| 6 | ComprehensiveNetIncome | -97,035,246 |
| 7 | BaseVar | 176,423,247 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.178 |
| 9 | EconomicCapitalRatio | 1.58 |
Edgar->Model Mapping
Feature Distribution
Change over Time
